Please login to the form below
Deloitte
This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.
The forefront of technology innovation
These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November
Latest news
-
Orphan drugs dominate FDA's record-breaking year
A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.
-
Pharma’s R&D productivity sinks to a new low
The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.
-
Artificial intelligence in healthcare
According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study
-
NHS bracing for 'no deal’ Brexit impact, including medicines
According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.
-
Health insurers will test blockchain for data handling
A Deloitte report on the application of blockchain to healthcare published in 2016 predicted that the technology could “provide a new model for health information exchanges (HIE) by making electronic medical
Orphan drugs dominate FDA's record-breaking year
Pharma’s R&D productivity sinks to a new low
Artificial intelligence in healthcare
NHS bracing for 'no deal’ Brexit impact, including medicines
Health insurers will test blockchain for data handling
More from news
Approximately 2 fully matching, plus 17 partially matching documents found.
Latest Intelligence
-
Product launches: making the most of your one shot
A recent analysis by Deloitte showed that most new drugs continue with the revenue trajectory set at launch – around 70% of products that miss expectations at launch continue doing so in
-
The new reality of building a corporate brand in pharma
According to Deloitte Insight’s 2021 Global Marketing Trends report, purpose is one of the key aspects necessary for businesses to flourish – they need to understand why they exist and who ... According to a 2019/20 Deloitte survey, 68% of biopharma
-
Successful product commercialisation: what can we learn from the rare disease setting?
Rare diseases: setting the gold standard for successful product launches. A recent Deloitte Insights white paper found that three product characteristics are strongly associated with strong launch performance: priority review and
-
Emerging use cases of blockchain in healthcare and the life sciences
The Prescrypt project, spearheaded by Deloitte in the Netherlands, is pursuing a completely different focus by working to put patients’ drug prescriptions on the blockchain for secure communication, usage tracking and
-
Start small but think big
Deloitte’s Future of Work initiative highlights the increasingly important role that contractors, freelancers and external experts play in building the flexible and agile teams that companies need.
Product launches: making the most of your one shot
The new reality of building a corporate brand in pharma
Successful product commercialisation: what can we learn from the rare disease setting?
Start small but think big
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest appointments
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
Prior to that, she held several senior communications roles, including chief communications officer at Deloitte, as well as senior roles at Novartis, Pfizer and leadership roles at biotech and healthcare communications
-
Paul Stockdale joins Oxford BioDynamics as CFO
Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
-
AlixPartners appoints new managing director
Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies. ... Prior to his experience at Deloitte
-
Sanofi appoints Diane Souza and Thomas Südhof
Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
-
Quantum Pharma promotes Chris Rigg to chief financial officer
He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.
New hires at Bristol-Myers Squibb, Acceleron and FerGene
Paul Stockdale joins Oxford BioDynamics as CFO
AlixPartners appoints new managing director
Quantum Pharma promotes Chris Rigg to chief financial officer
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Remote Patient Monitoring
The COVID-19 pandemic has brought into sharp focus the need to harness and leverage digital tools and technology for remote patient monitoring (RPM). With the onset of lockdown, and a sense of unease when visiting conventional clinical settings,
-
Impetus Digital Fireside Chat with Deloitte Europe: The Future of Learning
Ladana Edwards, Partner at Deloitte Central Europe and Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as
-
From nature to art galleries: thinking differently about healthcare
Deloitte, 2019.Last accessed February 2020, available at: ). Accenture, 2019. Last accessed February 2020, available at: . Public Health England. Last accessed February 2020, available at: . 44 (0) 20 7009 3100. Address:.
-
More tell, less sell: HCP-centric comms
New York, NY: 2017. 9. Deloitte. Pharma Adoption of Social Media.
-
Using contextual moments in marketing
Deloitte Digital.
More tell, less sell: HCP-centric comms
More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Digital strategist
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Events Executive
-
Depending on Experience
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital account director
-
Competitive
-
Digital project manager
-
Competitive
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Live Webinar: Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- Another Landmark Lucid Workiversary
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
- Biogen and Eisai present new data for controversial Alzheimer's drug Aduhelm at AAIC
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Onyx Health Launch Creative Studio After Record Year
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Paving the way for the HCP omnichannel experience: a guide for medical affairs
- EU approves bluebird bio’s CALD gene therapy Skysona
- Ashfield Health announces three new senior hires
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
